首页> 外国专利> PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT

PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT

机译:使用遗传学和临床风险评估相结合的预测性

摘要

Biomarkers and methods for screening expression levels of the biomarkers for predicting suicidality (referred herein to suicidal ideation and actions, future hospitalizations and suicide completion) are disclosed. Also disclosed are quantitative questionnaires and mobile applications for assessing affective state and for assessing socio-demographic and psychological suicide risk factors, and their use to compute scores that can predict suicidality. Finally, an algorithm that combines biomarkers and computer apps for identifying subjects who are at risk for committing suicide is disclosed, as well as methods to mitigate and prevent suicidality based on the biomarkers and computer apps.
机译:公开了生物标志物和用于筛选生物标志物表达水平以预测自杀性的生物标志物和方法(本文中指自杀的念头和行动,将来的住院治疗和自杀完成)。还公开了定量问卷和移动应用程序,用于评估情感状态以及评估社会人口统计学和心理自杀风险因素,以及用于计算可预测自杀性的分数。最后,公开了一种组合生物标记物和计算机应用程序以识别处于自杀危险中的受试者的算法,以及基于生物标记物和计算机应用程序的减轻和防止自杀的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号